SAIC Rises On Unusually High Volume (SAI)

NEW YORK ( TheStreet) -- SAIC (NYSE: SAI) is trading at unusually high volume Wednesday with 8.9 million shares changing hands. It is currently at 4.1 times its average daily volume and trading up 46 cents (+3.5%) at $13.62 as of 3:50 p.m. ET.

SAIC has a market cap of $4.39 billion and is part of the services sector and diversified services industry. Shares are up 7% year to date as of the close of trading on Tuesday.

SAIC, Inc. scientific, engineering, systems integration, and technical services and solutions to various branches of the U.S. military, agencies of the U.S. Department of Defense, the intelligence community, the U.S. Department of Homeland Security and the other U.S. The company has a P/E ratio of 16.6, above the average diversified services industry P/E ratio of 13.7 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates SAIC as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. You can view the full SAIC Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVUP to 95370 or select from multiple alert options.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing